Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien VP of Operations Dr. Chris Gemmiti to speak at Phacilitate Leaders World & World Stem Cell Summit

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien VP of Operations Dr. Chris Gemmiti to speak at Phacilitate Leaders World & World Stem Cell Summit

On Jan 23rd at 1:50pm, Sentien VP of Operations Dr. Chris Gemmiti will be speaking about Sentien’s ex vivo allogeneic MSC therapy for the treatment of systemic, immune-mediated inflammation.

Sentien Co-Founder Dr. Biju Parekkadan to Speak at Cellular Therapeutics in Trauma and Critical Care Conference

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Co-Founder Dr. Biju Parekkadan to Speak at Cellular Therapeutics in Trauma and Critical Care Conference

Sentien Biotechnologies Scientific Co-Founder, Dr. Biju Parekkadan, will be speaking at the Cellular Therapeutics in Trauma and Critical Care conference on 12/13 at 4:05pm.  He will be discussing ex vivo MSC therapy for the treatment of systemic inflammatory disease.

Sentien Executives Dr. Chris Gemmiti and Dr. Rita Barcia to Speak at Cell & Gene Therapy Bioprocessing & Commercialization conference

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Executives Dr. Chris Gemmiti and Dr. Rita Barcia to Speak at Cell & Gene Therapy Bioprocessing & Commercialization Conference

Dr. Chris Gemmiti, VP Operations at Sentien, will be speaking on an Outsourcing vs. Insourcing panel on September 10, 2019.

Dr. Rita Barcia, Executive Director of R&D at Sentien, will be speaking on a Next Generation Therapies panel on September 12, 2019.

Sentien Co-Founder Dr. Biju Parekkadan to Speak at American Society of Gene & Cell Therapy Annual Meeting on 4/29

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Co-Founder Dr. Biju Parekkadan to Speak at American Society of Gene & Cell Therapy Annual Meeting on 4/29

Sentien Biotechnologies Scientific Co-Founder, Dr. Biju Parekkadan, will be speaking at the American Society of Gene & Cell Therapy Annual Meeting on April 29, 2019 in Washington, DC.  He will be discussing Reprogramming Human Immune Responses Using Ex Vivo MSC Bioreactor Therapy.

Meet with us at the 2019 J.P. Morgan Healthcare Conference

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Meet with us at the 2019 J.P. Morgan Healthcare Conference

The Sentien team will be attending the 2019 J.P. Morgan Healthcare Conference. This event continues to be one of the life science industry’s largest conferences of the year. Contact us today to schedule a time to meet with our team and learn more about our business.
SCHEDULE A MEETING >

Sentien to sponsor and exhibit at the Cellular Therapeutics in Trauma & Critical Care Conference from May 17-19 in San Francisco

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien to sponsor and exhibit at the Cellular Therapeutics in Trauma & Critical Care Conference from May 17-19 in San Francisco

Sentien Biotechnologies is a sponsor and exhibitor at the 2017 Cellular Therapeutics & Critical Care Conference being held from May 17-19 in San Francisco. This is the third in a series of conferences, entitled “Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine: Looking towards the Future.”

Load More